RxDoctor Payments Data

Augusto Pichard

Interventional Cardiology · Washington, DCNPI 1669422960

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $108,141 of the $180,168 with a category attached, or 60.0%. Abbott accounts for 99.2% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2022 at $81,324 and has fallen 100.0% since, to $14 in 2025.

$180,168in general payments, 2019–2025

Across 173 payments — averaging $1041.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$179K
  • GE HealthCare$994
  • Medtronic$406
  • Boston Scientific$112
$1,745in research payments, 2019–2025

Across 2 payments — averaging $872.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$2K

What the payments were for

  • Consulting fees$108,14160%
  • Speaking & faculty fees$30,44317%
  • Grants$4060%
  • Travel & lodging$39,60022%
  • Food & beverage$1,5771%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott165$178,655
GE HealthCare6$994
Medtronic1$406
Boston Scientific1$112

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few interventional cardiology providers in District of Columbiato place this figure against a meaningful peer group, so we don't.

Other interventional cardiology in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →